TipRanks
Samil Pharmaceutical Co., Ltd. (KR:000520)
:000520
South Korea Market
000520
Samil Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see KR:000520 full AI Analyst Report?

Samil Pharmaceutical Co., Ltd. (000520) Income Statement

― Followers

Samil Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q2 2026), Samil Pharmaceutical Co., Ltd.'s total revenue was ₩50.60B, a decrease of -5.92% from the same quarter last year. In Q2, Samil Pharmaceutical Co., Ltd.'s net income was ₩-7.69B. See Samil Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₩ 210.37B₩ 219.70B₩ 196.35B₩ 179.68B₩ 134.25B
Gross Profit
₩ 67.44B₩ 80.91B₩ 72.21B₩ 67.49B₩ 48.99B
Operating Expenses
₩ 91.38B₩ 80.80B₩ 65.75B₩ 63.47B₩ 48.59B
Depreciation and Amortization
₩ 13.21B₩ 7.26B₩ 5.37B₩ 4.99B₩ 4.71B
EBITDA
₩ -10.72B₩ 8.71B₩ 10.34B₩ 10.31B₩ 6.15B
Operating Income
₩ -23.94B₩ 113.04M₩ 6.47B₩ 4.02B₩ 399.74M
Other Income/Expenses
₩ -13.22B₩ -3.73B₩ -5.05B₩ -2.96B₩ -5.16B
Pretax Income
₩ -37.16B₩ -3.61B₩ 1.42B₩ 1.06B₩ -4.76B
Net Income
₩ -34.59B₩ -5.63B₩ 1.66B₩ -28.29M₩ -5.35B
Per Share Metrics
Basic EPS
₩ -1.63K₩ -313.00₩ 116.16₩ -2.03₩ -386.63
Diluted EPS
₩ -1.63K₩ -313.00₩ 115.37₩ -2.03₩ -386.63
Weighted Average Shares Outstanding
 21.25M 17.98M 14.32M 13.91M 13.83M
Weighted Average Shares Outstanding (Diluted)
 21.25M 17.98M 14.42M 13.91M 13.83M
Currency in KRW

Samil Pharmaceutical Co., Ltd. Earnings and Revenue History